Victor Roy
@victorroy.bsky.social
physician, sociologist, health equity builder | asst prof Penn in family medicine + comm health | health + political economy project | book: Capitalizing a Cure (UC Press, 2023), http://bit.ly/3HnMXUQ | victorroy.com
This is all part of a broader trend of the "financialization" of health in the U.S. that I've described in the NEJM with colleagues last year: www.nejm.org/doi/full/10....
The Financialization of Health in the United States | NEJM
What do new forms of financial-sector ownership and influence in the U.S. health care
system, with their emphasis on short-term profit growth, mean for patients’ health
and pocketbooks?
www.nejm.org
February 10, 2025 at 5:12 PM
This is all part of a broader trend of the "financialization" of health in the U.S. that I've described in the NEJM with colleagues last year: www.nejm.org/doi/full/10....
Such payouts can come at the expense of enhancing affordable healthcare access, advancing research and development, and improving patient care.
At a time when Americans also face rising financial burdens from healthcare, there’s much more we could do to make it affordable and accessible.
At a time when Americans also face rising financial burdens from healthcare, there’s much more we could do to make it affordable and accessible.
February 10, 2025 at 5:12 PM
Such payouts can come at the expense of enhancing affordable healthcare access, advancing research and development, and improving patient care.
At a time when Americans also face rising financial burdens from healthcare, there’s much more we could do to make it affordable and accessible.
At a time when Americans also face rising financial burdens from healthcare, there’s much more we could do to make it affordable and accessible.
With as much as 70% of the US health system operating through tax-based financing, rewarding shareholders at this scale deserves greater scrutiny.
February 10, 2025 at 5:12 PM
With as much as 70% of the US health system operating through tax-based financing, rewarding shareholders at this scale deserves greater scrutiny.
These payouts went to dividends and buybacks, the latter of which is a financial maneuver that boosts short-term share prices.
Just 19 companies were responsible for 80% of these shareholder payouts, with pharma, biotech, and insurance the biggest players.
Why does this matter?
Just 19 companies were responsible for 80% of these shareholder payouts, with pharma, biotech, and insurance the biggest players.
Why does this matter?
February 10, 2025 at 5:12 PM
These payouts went to dividends and buybacks, the latter of which is a financial maneuver that boosts short-term share prices.
Just 19 companies were responsible for 80% of these shareholder payouts, with pharma, biotech, and insurance the biggest players.
Why does this matter?
Just 19 companies were responsible for 80% of these shareholder payouts, with pharma, biotech, and insurance the biggest players.
Why does this matter?
Our finding: Between 2001-2022, 92 healthcare companies in the S&P 500 made $2.72 trillion in total profits, and distributed $2.6 trillion (95%) to shareholders.
For example, Pfizer directed $363 billion, UnitedHealth $128 billion, and Hospital Corporation of America $89 billion to shareholders.
For example, Pfizer directed $363 billion, UnitedHealth $128 billion, and Hospital Corporation of America $89 billion to shareholders.
February 10, 2025 at 5:12 PM
Our finding: Between 2001-2022, 92 healthcare companies in the S&P 500 made $2.72 trillion in total profits, and distributed $2.6 trillion (95%) to shareholders.
For example, Pfizer directed $363 billion, UnitedHealth $128 billion, and Hospital Corporation of America $89 billion to shareholders.
For example, Pfizer directed $363 billion, UnitedHealth $128 billion, and Hospital Corporation of America $89 billion to shareholders.